CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue:
Total revenue	$ 40,785	$ 31,837
Costs and operating expenses:
Cost of revenue — amortization of intangible assets	33,472	33,472
Research and development	48,021	53,625
Sales and marketing	30,668	34,979
General and administrative	42,769	45,074
Total costs and operating expenses	176,550	185,444
Loss from operations	(135,765)	(153,607)
Other income:
Interest income	7,986	7,779
Other income (expense), net	256	(584)
Total other income, net	8,242	7,195
Loss before income taxes	(127,523)	(146,412)
Benefit from income taxes	34,336	40,199
Net loss	$ (93,187)	$ (106,213)
Net loss per share
Net loss per share—basic (in dollars per share)	$ (2.29)	$ (3.10)
Net loss per share—diluted (in dollars per share)	$ (2.29)	$ (3.10)
Weighted-average shares of common stock used in computing net loss per share—basic (in shares)	40,640,879	34,308,435
Weighted-average shares of common stock used in computing net loss per share—diluted (in shares)	40,640,879	34,308,435
Screening revenue
Revenue:
Total revenue	$ 39,832	$ 29,133
Costs and operating expenses:
Cost of revenue	21,244	17,123
Development Services
Revenue:
Total revenue	953	2,704
Costs and operating expenses:
Cost of revenue	$ 376	$ 1,171